Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Impact of Methamphetamine on microbiome dysbiosis and neuro-dysfunction in SIV infected rhesus macaques on antiretroviral therapy

Award Number: F31DA063401
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 09/01/2026
PERIOD OF PERFORMANCE END DATE: 08/31/2028

Group Awards By:

View Award Description

Impact of Methamphetamine on microbiome dysbiosis and neuro-dysfunction in SIV infected rhesus macaques on antiretroviral therapy - PROJECT SUMMARY Although potent antiretroviral therapy (ART) suppresses HIV replication to undetectable levels in peripheral blood in people with HIV (PWH), individuals on ART continue to experience systemic chronic inflammation and increased prevalence of comorbidities. HIV-associated neurocognitive disorders (HAND) still occur in PWH on ART, and the underlying mechanisms are largely unknown. Recent studies demonstrate that the gut-brain axis may play a critical role in contributing to HAND. Furthermore, for those who experience substance use disorders, such as Methamphetamine (Meth) use disorder, the HAND prevalence is even higher. During HIV infection, Meth exacerbates the pathogenesis of the virus while decreasing the effectiveness of ART. Evidence shows that both HIV infection and Meth use disorder cause gut dysbiosis. Dysbiosis has the potential to worsen pathogenesis because the gut microbiome communicates with the brain via the gut-brain axis and mediates the immune system function. A better understanding of how Meth use disorder contributes to HAND in PWH on ART is essential. This proposal will test a central hypothesis that Meth use disorder contributes to HIV-associated neurological dysfunction or onset of HAND through alterations of the microbiome and its metabolites via the gut- brain axis. This will be investigated using the Meth+/SIV+ART+ nonhuman primate model to firstly determining the effect of Meth on gut microbiome balance and its association with neurological dysfunction (Aim 1), and then characterizing the behavioral and physiological impacts of Meth use disorder (Aim 2). The proposed research will be conducted at Texas Biomedical Research Institute, which offers numerous training opportunities, available resources, and experienced mentors that will ensure successful completion of the project. Overall, the proposed research will explore how Meth impacts these processes via the gut-brain axis by examining changes in the microbiome and metabolites, and their subsequent effects on the brain. Results generated from this project will shed light on novel new mechanisms and provide valuable information for future therapeutics aimed at improving CNS function in PWH with Meth use disorder.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $41,679 )
2026	2026	THE UNIVERSITY OF TEXAS AT SAN ANTONIO	1 UTSA CIR	SAN ANTONIO	TX	78249	BEXAR	USA	Drug Use and Addiction Research Programs	001	1	5/11/2026	NEW	$0
2026	2026	THE UNIVERSITY OF TEXAS AT SAN ANTONIO	1 UTSA CIR	SAN ANTONIO	TX	78249	BEXAR	USA	Drug Use and Addiction Research Programs	000	1	5/11/2026	NEW	$41,679
														Subtotal = $41,679

Grand Total All Awards = $41,679

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Impact of Methamphetamine on microbiome dysbiosis and neuro-dysfunction in SIV infected rhesus macaques on antiretroviral therapy

Award Number: F31DA063401

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 09/01/2026

PERIOD OF PERFORMANCE END DATE: 08/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer